368 related articles for article (PubMed ID: 29428281)
1. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
Shaffer BL; Norton ME
Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
[TBL] [Abstract][Full Text] [Related]
2. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
3. State-wide utilization and performance of traditional and cell-free DNA-based prenatal testing pathways: the Victorian Perinatal Record Linkage (PeRL) study.
Lindquist A; Hui L; Poulton A; Kluckow E; Hutchinson B; Pertile MD; Bonacquisto L; Gugasyan L; Kulkarni A; Harraway J; Howden A; McCoy R; Da Silva Costa F; Menezes M; Palma-Dias R; Nisbet D; Martin N; Bethune M; Poulakis Z; Halliday J
Ultrasound Obstet Gynecol; 2020 Aug; 56(2):215-224. PubMed ID: 31625225
[TBL] [Abstract][Full Text] [Related]
4. Performance of a cell-free DNA prenatal screening test, choice of prenatal procedure, and chromosome conditions identified during pregnancy after low-risk cell-free DNA screening.
Scarff KL; Flowers N; Love CJ; Archibald AD; Hunt CE; Giouzeppos O; Elliott J; Delatycki MB; Pertile MD
Prenat Diagn; 2023 Feb; 43(2):213-225. PubMed ID: 36617980
[TBL] [Abstract][Full Text] [Related]
5. Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.
Guy C; Haji-Sheikhi F; Rowland CM; Anderson B; Owen R; Lacbawan FL; Alagia DP
Mol Genet Genomic Med; 2019 Mar; 7(3):e545. PubMed ID: 30706702
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.
Norton ME; Baer RJ; Wapner RJ; Kuppermann M; Jelliffe-Pawlowski LL; Currier RJ
Am J Obstet Gynecol; 2016 Jun; 214(6):727.e1-6. PubMed ID: 26709085
[TBL] [Abstract][Full Text] [Related]
7. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
Gray KJ; Wilkins-Haug LE
Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y
Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627
[TBL] [Abstract][Full Text] [Related]
9. Cell-free fetal DNA screening for detection of microdeletion syndromes: a cost-effectiveness analysis.
Avram CM; Shaffer BL; Sparks TN; Allen AJ; Caughey AB
J Matern Fetal Neonatal Med; 2021 Jun; 34(11):1732-1740. PubMed ID: 31327283
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive screening by cell-free DNA for 22q11.2 deletion: Benefits, limitations, and challenges.
Grati FR; Gross SJ
Prenat Diagn; 2019 Jan; 39(2):70-80. PubMed ID: 30625249
[TBL] [Abstract][Full Text] [Related]
11. Where have all the trisomies gone?
Palomaki GE; Lambert-Messerlian GM; Haddow JE
Am J Obstet Gynecol; 2016 Nov; 215(5):583-587.e1. PubMed ID: 27793310
[TBL] [Abstract][Full Text] [Related]
12. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.
Choe SA; Seol HJ; Kwon JY; Park CW; Kim M; Lee JY; Kim MA; Hwang HS; Na S; Shim JY; Kim K; Ryu HM
J Korean Med Sci; 2021 Jan; 36(4):e27. PubMed ID: 33496086
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
Skrzypek H; Hui L
Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
[TBL] [Abstract][Full Text] [Related]
14. Performance of prenatal cfDNA screening for sex chromosomes.
Martin K; Dar P; MacPherson C; Egbert M; Demko Z; Parmar S; Hashimoto K; Haeri S; Malone F; Wapner RJ; Roman AS; Khalil A; Faro R; Madankumar R; Strong N; Silver RM; Vohra N; Hyett J; Rabinowitz M; Kao C; Hakonarson H; Jacobsson B; Norton ME
Genet Med; 2023 Aug; 25(8):100879. PubMed ID: 37154148
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes.
Liang D; Cram DS; Tan H; Linpeng S; Liu Y; Sun H; Zhang Y; Tian F; Zhu H; Xu M; Wang H; Yu F; Wu L
Genet Med; 2019 Sep; 21(9):1998-2006. PubMed ID: 30828085
[TBL] [Abstract][Full Text] [Related]
16. Detection of fetal subchromosomal aberration with cell-free DNA screening led to diagnosis of parental translocation: Review of 11344 consecutive cases in a university hospital.
Qian YQ; Wang XQ; Chen M; Luo YQ; Yan K; Yang YM; Liu B; Wang LY; Huang YZ; Li HG; Pan HY; Jin F; Dong MY
Eur J Med Genet; 2019 Feb; 62(2):115-123. PubMed ID: 29929010
[TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA for the detection of fetal aneuploidy.
Goldwaser T; Klugman S
Fertil Steril; 2018 Feb; 109(2):195-200. PubMed ID: 29447662
[TBL] [Abstract][Full Text] [Related]
18. Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians.
Agatisa PK; Mercer MB; Coleridge M; Farrell RM
J Genet Couns; 2018 Dec; 27(6):1374-1385. PubMed ID: 29951719
[TBL] [Abstract][Full Text] [Related]
19. Update in non-invasive prenatal testing.
D'ambrosio V; Squarcella A; Vena F; Di Mascio D; Corno S; Pajno C; Piccioni MG; Brunelli R; Pizzuti A; Benedetti Panici P; Giancotti A
Minerva Ginecol; 2019 Feb; 71(1):44-53. PubMed ID: 30318870
[TBL] [Abstract][Full Text] [Related]
20. The importance of pre- and post-test counseling for prenatal cell-free DNA screening for common fetal aneuploidies.
Stefanovic V
Expert Rev Mol Diagn; 2019 Mar; 19(3):201-215. PubMed ID: 30657716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
